Table 4.

One-way sensitivity analysis results showing the net clinic balance (higher is better) and the change in the net clinic balance arising from the use of other iron formulations relative to iron isomaltoside 1000

Analysis	IIM	FCM		IS		LMWID
	Net balance (€)	Net balance (€)	Δ from IIM (€)	Net balance (€)	Δ from IIM (€)	Net balance (€)	Δ from IIM (€)
Base case	42,736	36,327	− 6408	10,194	− 32,542	32,403	− 10,333
100% elective procedures	39,028	33,572	−5456	9564	−29,464	31,167	−7861
100% non-elective procedures	55,434	45,765	−9669	12,352	−43,083	36,636	−18,799
8 infusion slots per half day	23,187	18,914	−4272	1492	−21,694	16,298	−6889
16 infusion slots per half day	62,285	53,740	−8544	18,896	−43,389	48,507	−13,777
Full consultant oversight	37,128	30,720	−6408	4586	−32,542	26,795	−10,333
No ward stay reduction with pre-operative iron	35,270	30,779	−4491	8926	−26,344	29,914	−5356
No reduction in hospital readmission with pre-operative iron	38,156	32,924	−5232	9416	−28,740	30,876	−7280
Ganzoni equation-based iron need calculation	46,332	30,369	−15,963	10,504	−35,828	35,365	−10,967
Froessler et al. baseline characteristics	48,390	36,173	−12,217	10,608	−37,723	37,085	−11,329

€ 2019 Euros, FCM ferric carboxymaltose, IIM iron isomaltoside 1000, ICU intensive care unit, IS iron sucrose, LMWID low molecular weight iron dextran